Renovacor
Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and related diseases. The company’s lead program in BAG3-associated dilated cardiomyopathy (DCM) uses gene transfer technology to address the monogenic cause of this severe form of heart failure. Renovacor’s vision is to bring life-changing therapies to patients living with serious genetic cardiovascular and related diseases, by developing medicines that target the underlying cause of disease and provide a transformative benefit and significant improvement to quality of life.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
8
11 to 50 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 3 verified contacts at Renovacor
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- OB
Olga Baboshina
Director of Regulatory Affairs-cmc · Other
EmailPhone - MC
Matthew Coggins
Senior Medical Director, Translational Science · Research & Development
EmailPhone - FD
Fred Driscoll
Chief Financial Officer · Finance & Accounting
EmailPhone
Showing 3 of 3 verified contacts
Top roles at Renovacor
3 distinct titles indexed · top 3 shown.
- 1chief financial officer
- 1director of regulatory affairs-cmc
- 1senior medical director, translational science
Sign up to unlock all 3 contacts at Renovacor
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Renovacor
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.